Viatris Inc. announced that it has closed its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. The transaction was first announced on November 7 as part of Viatris’ strategic update. Former Oyster Point Pharma CEO, Jeffrey Nau, Ph.D., MMS, will lead the new division.
Featured Posts
Leading scientists advising the World Health Organization said they wanted a “more realistic picture” about the COVID-19 situation from China’s top experts at a key meeting on Tuesday as worries grow about the rapid spread of the virus.
Gilead receives the rights to exclusively license EVOQ’s NanoDisc Technology to develop and commercialize immunotherapy products for rheumatoid arthritis and lupus.
2023 marks the 40th anniversary of the Orphan Drug Act (ODA) and kicks off a year of renewed hope and promise for developing rare disease medicines.
The European Union has offered free COVID-19 vaccines to China, the EU executive said on Tuesday, as infections there surged following Beijing’s relaxation of its “zero-COVID” policies.
State media in China played down the severity of a surge of COVID-19 infections ahead of an expected briefing on Tuesday by its scientists to the World Health Organization, which is hoping for a “detailed discussion” on the evolution of the virus.
Blacksmith Medicines, Inc. and Forge Therapeutics announced that the companies have signed a definitive merger agreement to leverage their combined chemistry platforms, creating a leading biopharma dedicated to discovering and developing medicines targeting a large class of proteins called metalloenzymes, with initial focus on oncology and infection.
Malawi has delayed the opening of public schools in the southern African country’s two major cities of Blantyre and Lilongwe, the health minister said Monday, to try to slow down a surge in cholera deaths.
European Union government health officials will hold talks on Wednesday on a coordinated response to the surge in COVID-19 infections in China, the Swedish EU presidency said on Monday, after December talks concluded with no decisions on the matter.
France on Sunday urged European Union peers to test Chinese travelers for COVID after Paris decided to do so amid an outbreak sweeping the country.